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OBJECTIVE— Neonates of women with gestational diabetes mellitus (GDM) have reduced
levels of arachidonic acid (AA) (20:4 n-6) and docosahexaenoic acid (DHA) (22:6 n-3). To assess
whether this is the result of impaired placental transfer or endogenous fetal metabolism, fatty
acids in umbilical venous and arterial plasma were analyzed in neonates of GDM women.
RESEARCH DESIGN AND METHODS— Fatty acids were analyzed by gas chroma-
tography in the plasma of 15 subjects with GDM and 30 healthy control subjects undergoing
elective cesarean section and in vein and artery cord blood collected separately.
RESULTS— The percentages of AA (20:4 n-6), DHA (22:6 n-3), and total n-6 or n-3 poly-
unsaturated fatty acids (PUFAs) as well as total PUFAs were lower in umbilical arterial but not in
venous plasma of neonates of the GDM versus the control group.
CONCLUSIONS— An altered handling or metabolism of long-chain PUFAs by the fetus
rather than impaired placental transfer seems to be responsible for the lower proportion of those
fatty acids in the plasma of neonates of GDM mothers.
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W hereas plasma levels of arachi-donic acid (AA) and docosahexae-noic acid (DHA) in neonates of
women with type 1 diabetes (1), type 2
diabetes (2), or gestational diabetes mel-
litus (GDM) (3) are low, the levels of AA
and DHA in GDM women are normal or
even enhanced (4) compared with those
of healthy control subjects. Because it is
unknown whether this decline in neo-
nates is due to impaired transfer or altered
intrauterine fetal metabolism, we ana-
lyzed fatty-acid profiles in umbilical ve-
nous and arterial plasma and in control
and GDM mothers at the time of cesarean
delivery.
RESEARCH DESIGN AND
METHODS— Fifteen Caucasian women
with GDM (mean  SD age 32.3  1.0
years) diagnosed by an abnormal 100-g
oral glucose tolerance test (5) and 30
healthy control subjects (35.9  1.1
years; P  0.05) were enrolled. The Uni-
versity of Milan Ethical Board approved
the protocol, and informed consent was
obtained. After diagnosis, patients began
a diet together with blood glucose self-
monitoring (6). All women underwent
elective cesarean after an overnight fast.
Pregnancies were singleton, and none of
the neonates showed malformations, ab-
normal karyotypes, or signs of distress.
Blood samples from the maternal radial
vein and from the umbilical vein and ar-
tery were collected in EDTA. The umbil-
ical samples were obtained from a cord
segment doubly clamped immediately af-
ter fetal extraction, and plasma aliquots
were stored at 80°C until analysis.
Sample analysis
Lipids were extracted and put in a 2:1
mixture of chloroform and methanol con-
taining 0.005% butylate hydrotoluene.
Fatty acids were transesterified with
methanolic hydrochloride, and fatty acid
methyl esters were separated and ana-
lyzed on a PerkinElmer Autosystem gas
chromatograph (Norwalk, CT) (7). Re-
sults are expressed as percent (mg/100
mg of fatty acids) of all detected fatty
acids with a chain length of 12–24 car-
bon atoms.
Statistical analysis
Statistical differences were evaluated by
one-way ANOVA. When statistically sig-
nificant differences appeared (P  0.05),
they were assessed by Tukey’s multiple
range comparison test. Student’s t test was
used to compare values between two
groups.
RESULTS— Whereas no major differ-
ences were found between the GDM and
control groups in the percent of the indi-
vidual fatty acids analyzed from maternal
plasma, umbilical cord plasma values
showed interesting differences (Table 1).
Palmitic acid values did not differ be-
tween umbilical venous or arterial plasma
and the plasma of the mothers. However,
stearic acid was higher in both umbilical
venous and arterial plasma than in mater-
nal plasma. A similar comparison was also
found when total saturated fatty acids
were estimated, although no difference
between the GDM and control groups was
found. The percent of palmitoleic acid
was slightly higher, whereas that of oleic
acid and total monounsaturated fatty ac-
ids was lower, in both umbilical venous
and arterial plasma than in the mothers’
plasma. No differences were found be-
tween the GDM and control groups for
any of them.
Concerning the n-6 fatty acids, lino-
leic acid was lower, whereas eicosatrie-
noic acid (20:3 n-6) was higher, in
umbilical venous and arterial plasma than
in maternal plasma, with no differences
between the GDM and control groups.
Also, whereas AA was much higher in
umbilical venous and arterial plasma than
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in maternal plasma, no differences were
found between the GDM and control
groups in maternal or umbilical venous
plasma, although umbilical artery values
appeared lower in the GDM than in the
control group. A lower percent of n-6
polyunsaturated fatty acids (PUFAs) was
found in the umbilical arteries, but not in
the umbilical veins, of the GDM group
than of the control group.
For n-3 fatty acids, the percent of
-linolenic acid in maternal plasma did
not differ between the GDM and control
groups, and -linolenic acid was unde-
tectable in umbilical venous and arterial
plasma. The percent of DHA in both the
control and GDM groups was higher in
umbilical venous and arterial plasma than
in maternal plasma, umbilical artery DHA
values in the GDM group were lower than
those in the control group, and no differ-
ences between the two groups were found
in either maternal plasma or umbilical ve-
nous plasma. Similar intergroup compar-
isons were found for both n-3 PUFAs and
total PUFAs, with values being lower in
the umbilical arteries, but not in the um-
bilical veins, of the GDM than in those of
the control group.
CONCLUSIONS— In agreement
with previous reports (8), the plasma fat-
ty-acid profile did not differ between
GDM and control subjects. However, we
show here for the first time that whereas
the fatty-acid profile in umbilical venous
plasma of GDM subjects does not differ
from that of control subjects, a lower per-
cent of both AA and DHA and of n-6 and
n-3 PUFAs appears in GDM umbilical ar-
terial plasma than in control umbilical ar-
terial plasma. When the umbilical plasma
fatty-acid profile is compared with the
maternal plasma profile, there are higher
proportions of saturated fatty acids but
lower proportions of the two essential
n-6 and n-3 fatty acids, linoleic acid and
-linolenic acid, whereas proportions of
their respectively derived long-chain PU-
FAs, AA and DHA, are higher in umbilical
plasma. Such enhancement in AA and
DHA in fetal circulation is called “magni-
fication” and interpreted as a result of
their effective transfer throughout the pla-
centa (9). However, their synthesis by the
fetus from their respective precursors
cannot be discarded (10,11). Thus, the
decreased percent of the long-chain
PUFA precursors on the fetal side may
only be a reflection of their active conver-
sion rather than a limited placental trans-
fer. In fact, although not directly
measured under in vivo conditions, pla-
cental transfer of both linoleic and -lin-
olenic acid has been demonstrated to be
even more efficient than that of AA using
an ex vivo placental perfusion system
(12).
Umbilical artery blood arrives at the
placental capillaries from fetal tissues,
whereas umbilical vein blood comes from
the placental capillaries; its composition
is therefore dependent on placental trans-
fer activity. Because the placenta lacks
desaturase activity (13), the higher pro-
portions of AA and DHA in umbilical ve-
Table 1—Percent of fatty acids (mg/100 mg fatty acids) in plasma of control (n  30) and
GDM (n 15) pregnant women at cesarean section delivery and in their respective cord blood
Maternal vein Umbilical vein Umbilical artery P
Palmitic acid (16:0)
Control 27.3  0.4 25.4  1.1 26.5  1.6 NS
GDM 27.8  0.5ab 25.4  1.7a 31.6  2.6b 0.0384
Stearic acid (18:0)
Control 7.00  0.49a 19.8  1.9b 16.3  2.1b 0.0000
GDM 6.83  0.64a 19.8  2.9b 13.2  2.1ab 0.0001
Total SFAs
Control 36.2  0.5a 47.1  1.1b 44.7  1.1b 0.0000
GDM 36.4  0.7a 47.2  2.0b 46.6  1.9b 0.0000
Palmitoleic acid (16:1 n-7)
Control 3.24  0.15 3.62  0.29 3.77  0.33 NS
GDM 2.73  0.21a 3.93  0.47ab 4.04  0.69b 0.0026
Oleic acid (18:1 n-9)
Control 26.6  0.6a 19.4  0.5b 18.4  0.9b 0.0000
GDM 25.9  0.8a 20.4  1.0b 20.6  1.4b 0.0002
Total MUFAs
Control 30.4  0.6a 24.5  0.7b 23.4  1.1b 0.0000
GDM 29.3  0.9 25.8  1.5 27.5  1.5 NS
Linoleic acid (18:2 n-6)
Control 22.6  0.7a 7.81  0.30b 9.32  0.93b 0.0000
GDM 23.1  1.0a 7.63  0.40b 7.73  0.68b 0.0000
Eicosatrienoic acid (20:3 n-6)
Control 1.40  0.12a 2.47  0.19b 2.39  0.28b 0.0001
GDM 1.25  0.13a 2.32  0.11b 2.11  0.34b 0.0002
AA (20:4 n-6)
Control 5.11  0.20a 12.2  0.3b 12.3  0.5b 0.0000
GDM 5.67  0.20a 11.4  0.8b 10.2  0.8b* 0.0000
Total n-6 fatty acids
Control 29.7  0.8a 23.6  0.6b 26.1  0.9b 0.0000
GDM 30.6  1.0a 22.5  1.2b 22.4  1.6b* 0.0000
-linolenic acid (18:3 n-3)
Control 0.413  0.060 ND ND
GDM 0.354  0.064 ND ND
DHA (22:6 n-3)
Control 2.44  0.11a 3.99  0.16b 4.32  0.19b 0.0000
GDM 2.76  0.20a 3.96  0.32b 3.15  0.31ab† 0.0083
Total n-3 fatty acids
Control 3.64  0.15a 5.15  0.43b 5.69  0.41b 0.0006
GDM 3.94  3.49 4.55  0.37 3.57  0.30† NS
Total PUFAs
Control 33.6  0.8a 28.8  0.7b 31.8  1.1a 0.0004
GDM 34.6  0.9a 27.1  1.2b 25.9  1.7b† 0.0000
Data are means SEM. Tukey’s test was used to determine differences between maternal, umbilical venous,
and arterial plasma after one-way ANOVA. Different letters in a row indicate significant differences. The
difference between GDM and control values were significantly different at *P  0.05 and †P  0.01 by
Student’s t test. Total SFAs, sum of 12:0, 14:0, 16:0, 18:0, 20:0, 22:0, 23:0, and 24:0. Total MUFAs, sum of
16:1, 18:1, and 20:1. Total n-6 fatty acids, sum of 18:2, 18:3, 20:2, 20:3, 20:4, 22:2, 22:4, and 22:5. Total
n-3 fatty acids, sum of 18:3, 20:3, 20:5, 22:3, 22:5, and 22:6. Total PUFAs, sum of total n-6 plus n-3. MUFAs,
monounsaturated fatty acids; SFAs, saturated fatty acids.
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nous plasma than in maternal plasma
would indicate that their placental trans-
fer is unimpaired. However, the de-
creased proportions of AA, DHA, and
total n-6 and n-3 PUFAs in the umbilical
arteries of GDM fetuses would indicate
their enhanced utilization by fetal tissues.
Further studies are needed to establish
the mechanism involved and its implica-
tions for fetal and postnatal growth.
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